doxorubicin hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
25 FDA-registered drug labelers
Actavis Pharma, Inc.
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Amneal Pharmaceuticals LLC
Baxter Healthcare Company
Baxter Healthcare Corporation
BluePoint Laboratories
Dr. Reddy's Laboratories Inc
Fresenius Kabi USA, LLC
Gemini PharmChem Mannheim GmbH
Gland Pharma Limited
GlaxoSmithKline Manufacturing SpA
Hikma Pharmaceuticals USA Inc.
Lupin Pharmaceuticals, Inc.
Meiji Seika Pharma Co., Ltd.
MicroBiopharm Japan Co., Ltd.
Mylan Institutional LLC
NorthStar RxLLC
Olon SpA
Pfizer Laboratories Div Pfizer Inc
Sagent Pharmaceuticals
Sicor S.r.l.
Sun Pharmaceutical Industries, Inc.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •Doxorubicin Hydrochloride
- •Doxil
- •Doxorubicin Hydrochloride Liposome
- •doxorubicin hydrochloride, Liposomal
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS25316-40-9
PubChem CID443939
DTXSIDDTXSID3030636
FormulaC27H30ClNO11
Mol. Weight580 g/mol
SMILESCC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
Data Sources
4439392026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/doxorubicin hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/doxorubicin hydrochloride.json
CAS 25316-40-92026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json